• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Express Scripts

Express Scripts

Express Scripts ESRX 4 Star

Last Price$73.65Day Change (%)0.81%
Open Price$73.23Day Change ($)0.59
Day Range73.05–73.7152-Week Range59.20–79.37

As of Fri 10/24/2014 03:39 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  2. HITRUST and Healthcare Leaders Collaborate to Establish Cyber Threat XChange to Improve and Accelerate Cyber Threat Detection and Response

    HITRUST and Healthcare Leaders Collaborate to Establish Cyber Threat XChange to Improve and Accelerate Cyber Threat Detection and Response

  3. Walgreens Expands Preferred Network Relationships to Nine National Medicare Part D Plan Sponsors

    Walgreens Expands Preferred Network Relationships to Nine National Medicare Part D Plan Sponsors

  4. A Rare, Wide-Moat Find in a Market With Few Values

    Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

  5. Market Overreaction Makes Express Scripts Even More Attractive

    Misunderstanding on private health insurance exchanges could mean opportunity for investors.

  6. Health Care: Some Healthy Bargains Still Remain

    While the sector looks fairly valued overall, we still see several stocks that offer attractive valuations across the different industries, including pharmacy benefit managers.

  7. Fixed Income Roadmap: Where Next For Bonds?

    Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...

  8. A Few Picks to Tide Over the Bargain-Hunters

    In a fully valued market, there are worse things than buying wide-moat names at decent discounts.

  9. Catamaran Sails Through Another Solid Quarter

    We believe its acquisition strategy puts the PBM on the right course.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.